Patent details

Basic Information

Publication number:

EP2744342

PCT Application Number:

US2012051349

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP128245990

PCT Publication Number:

WO2013025992

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

THERAPEUTIC METHODS

French Title of Invention:

PROCÉDÉS THÉRAPEUTIQUES

German Title of Invention:

THERAPEUTISCHE VERFAHREN

SPC Number:

Dates

Filing date:

17/08/2012

Grant date:

24/04/2019

EP Publication Date:

25/06/2014

PCT Publication Date:

21/02/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/04/2019

EP B1 Publication Date:

24/04/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/08/2019

Expiration date:

17/08/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/04/2019

 

 

Name:

GlaxoSmithKline LLC

Address:

251 Little Falls Drive, Wilmington, DE 19808, United States (US)

Inventor

1

Name:

PEAT, Andy

Address:

United States (US)

2

Name:

WALKER, Jill

Address:

United States (US)

3

Name:

SHOTWELL, Brad

Address:

United States (US)

4

Name:

VOITENLEITNER, Christian

Address:

United States (US)

Priority

1

Priority Number:

201161524429 P

Priority Date:

17/08/2011

Priority Country:

United States (US)

2

Priority Number:

201161526787 P

Priority Date:

24/08/2011

Priority Country:

United States (US)

Classification

IPC classification:

A01N 55/08; A61K 31/69; A61P 31/12;

Publication

European Patent Bulletin

Issue number:

201917

Publication date:

24/04/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages